321 related articles for article (PubMed ID: 33125080)
1. Relationship of IGF-1 and IGF-Binding Proteins to Disease Severity and Glycemia in Nonalcoholic Fatty Liver Disease.
Stanley TL; Fourman LT; Zheng I; McClure CM; Feldpausch MN; Torriani M; Corey KE; Chung RT; Lee H; Kleiner DE; Hadigan CM; Grinspoon SK
J Clin Endocrinol Metab; 2021 Jan; 106(2):e520-e533. PubMed ID: 33125080
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels.
Fusco A; Miele L; D'Uonnolo A; Forgione A; Riccardi L; Cefalo C; Barini A; Bianchi A; Giampietro A; Cimino V; Landolfi R; Grieco A; De Marinis L
Clin Endocrinol (Oxf); 2012 Oct; 77(4):531-6. PubMed ID: 22077984
[TBL] [Abstract][Full Text] [Related]
3. The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease.
Chishima S; Kogiso T; Matsushita N; Hashimoto E; Tokushige K
Intern Med; 2017; 56(5):473-480. PubMed ID: 28250290
[TBL] [Abstract][Full Text] [Related]
4. Expression of IGF-1 receptor and GH receptor in hepatic tissue of patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Osganian SA; Subudhi S; Masia R; Drescher HK; Bartsch LM; Chicote ML; Chung RT; Gee DW; Witkowski ER; Bredella MA; Lauer GM; Corey KE; Dichtel LE
Growth Horm IGF Res; 2022 Aug; 65():101482. PubMed ID: 35780715
[TBL] [Abstract][Full Text] [Related]
5. Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men.
Münzer T; Rosen CJ; Harman SM; Pabst KM; St Clair C; Sorkin JD; Blackman MR
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E1006-13. PubMed ID: 16390864
[TBL] [Abstract][Full Text] [Related]
6. Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD.
Polyzos SA; Perakakis N; Boutari C; Kountouras J; Ghaly W; Anastasilakis AD; Karagiannis A; Mantzoros CS
J Clin Endocrinol Metab; 2020 Mar; 105(3):e390-400. PubMed ID: 31690932
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factors, insulin-like growth factor-binding proteins, insulin-like growth factor-binding protein-3 protease, and growth hormone-binding protein in lipodystrophic human immunodeficiency virus-infected patients.
Haugaard SB; Andersen O; Hansen BR; Orskov H; Andersen UB; Madsbad S; Iversen J; Flyvbjerg A
Metabolism; 2004 Dec; 53(12):1565-73. PubMed ID: 15562401
[TBL] [Abstract][Full Text] [Related]
8. Relationship between serum circulating insulin-like growth factor-1 and liver fat in the United States.
Runchey SS; Boyko EJ; Ioannou GN; Utzschneider KM
J Gastroenterol Hepatol; 2014 Mar; 29(3):589-96. PubMed ID: 24716226
[TBL] [Abstract][Full Text] [Related]
9. Hepatic growth hormone receptor, insulin-like growth factor I, and insulin-like growth factor-binding protein messenger RNA expression in pediatric liver disease.
Holt RI; Crossey PA; Jones JS; Baker AJ; Portmann B; Miell JP
Hepatology; 1997 Dec; 26(6):1600-6. PubMed ID: 9398004
[TBL] [Abstract][Full Text] [Related]
10. Ovarian expression of insulin-like growth factor-I (IGF-I), IGF binding proteins, and growth hormone (GH) receptor in heifers actively immunized against GH-releasing factors.
Cohick WS; Armstrong JD; Whitacre MD; Lucy MC; Harvey RW; Campbell RM
Endocrinology; 1996 May; 137(5):1670-7. PubMed ID: 8612500
[TBL] [Abstract][Full Text] [Related]
11. Growth Hormone Releasing Hormone Reduces Circulating Markers of Immune Activation in Parallel with Effects on Hepatic Immune Pathways in Individuals with HIV-infection and Nonalcoholic Fatty Liver Disease.
Stanley TL; Fourman LT; Wong LP; Sadreyev R; Billingsley JM; Feldpausch MN; Zheng I; Pan CS; Boutin A; Lee H; Corey KE; Torriani M; Kleiner DE; Chung RT; Hadigan CM; Grinspoon SK
Clin Infect Dis; 2021 Aug; 73(4):621-630. PubMed ID: 33852720
[TBL] [Abstract][Full Text] [Related]
12. Chronic heat stress increases insulin-like growth factor-1(IGF-1) but does not affect IGF-binding proteins in growing pigs.
Xin H; Zhang X; Sun D; Zhang C; Hao Y; Gu X
J Therm Biol; 2018 Oct; 77():122-130. PubMed ID: 30196890
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial.
Koutkia P; Canavan B; Breu J; Torriani M; Kissko J; Grinspoon S
JAMA; 2004 Jul; 292(2):210-8. PubMed ID: 15249570
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor system in patients with HIV infection: effect of exogenous growth hormone administration.
Mynarcik DC; Frost RA; Lang CH; DeCristofaro K; McNurlan MA; Garlick PJ; Steigbigel RT; Fuhrer J; Ahnn S; Gelato MC
J Acquir Immune Defic Syndr; 1999 Sep; 22(1):49-55. PubMed ID: 10534146
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor I and insulin-like growth factor-binding proteins in bovine serum and follicular fluid before and after the preovulatory surge of luteinizing hormone.
Funston RN; Seidel GE; Klindt J; Roberts AJ
Biol Reprod; 1996 Dec; 55(6):1390-6. PubMed ID: 8949898
[TBL] [Abstract][Full Text] [Related]
16. Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans.
Olivecrona H; Hilding A; Ekström C; Barle H; Nyberg B; Möller C; Delhanty PJ; Baxter RC; Angelin B; Ekström TJ; Tally M
J Clin Endocrinol Metab; 1999 Feb; 84(2):553-60. PubMed ID: 10022415
[TBL] [Abstract][Full Text] [Related]
17. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
[TBL] [Abstract][Full Text] [Related]
18. Novel relationships of age, visceral adiposity, insulin-like growth factor (IGF)-I and IGF binding protein concentrations to growth hormone (GH) releasing-hormone and GH releasing-peptide efficacies in men during experimental hypogonadal clamp.
Veldhuis JD; Keenan DM; Bailey JN; Adeniji AM; Miles JM; Bowers CY
J Clin Endocrinol Metab; 2009 Jun; 94(6):2137-43. PubMed ID: 19351723
[TBL] [Abstract][Full Text] [Related]
19. Short-term effects of NPH insulin, insulin detemir, and insulin glargine on the GH-IGF1-IGFBP axis in patients with type 1 diabetes.
Ma Z; Christiansen JS; Laursen T; Lauritzen T; Frystyk J
Eur J Endocrinol; 2014 Oct; 171(4):471-9. PubMed ID: 25005937
[TBL] [Abstract][Full Text] [Related]
20. Determinants of GH-releasing hormone and GH-releasing peptide synergy in men.
Veldhuis JD; Bowers CY
Am J Physiol Endocrinol Metab; 2009 May; 296(5):E1085-92. PubMed ID: 19240251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
